1. 1, 2, 3-Triazole-fused spirochromenes as potential anti-tubercular agents: synthesis and biological evaluation. Issue 30 (9th May 2018) Authors: Ashok, Dongamanti; Chiranjeevi, Pamula; Kumar, Aamate Vikas; Sarasija, Madderla; Krishna, Vagolu Siva; Sriram, Dharmarajan; Balasubramanian, Sridhar Journal: RSC advances Issue: Volume 8:Issue 30(2018) Page Start: 16997 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 5-Chloro-2-thiophenyl-1, 2, 3-triazolylmethyldihydroquinolines as dual inhibitors of Mycobacterium tuberculosis and influenza virus: Synthesis and evaluation. Issue 18 (15th September 2019) Authors: Marvadi, Sandeep Kumar; Krishna, Vagolu Siva; Sinegubova, Ekaterina O.; Volobueva, Alexandrina S.; Esaulkova, Yana L.; Muryleva, Anna A.; Tentler, Dmitry G.; Sriram, Dharmarajan; Zarubaev, Vladimir V.; Kantevari, Srinivas Journal: Bioorganic & medicinal chemistry letters Issue: Volume 29:Issue 18(2019) Page Start: 2664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Facile Synthesis and Antituberculosis Properties of Almazole D and Its Enantiomer. Issue 3 (30th January 2017) Authors: Lade, Dhanaji M.; Krishna, Vagolu Siva; Sriram, Dharmarajan; Rode, Haridas B. Journal: ChemistrySelect Issue: Volume 2:Issue 3(2017) Page Start: 1250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Quinoline Compound Inhibits the Replication of Dengue virus Serotypes 1–4 in Vero Cells. Issue 5 (July 2018) Authors: Beesetti, Hemalatha; Tyagi, Poornima; Medapi, Brahmam; Krishna, Vagolu Siva; Sriram, Dharmarajan; Khanna, Navin; Swaminathan, Sathyamangalam Journal: Antiviral therapy Issue: Volume 23:Issue 5(2018) Page Start: 385 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A robust synthesis of functionalized 2H-indazoles via solid state melt reaction (SSMR) and their anti-tubercular activity. Issue 7 (1st April 2017) Authors: Vidyacharan, Shinde; Adhikari, Chandan; Krishna, Vagolu Siva; Reshma, Rudraraju Srilakshmi; Sriram, Dharmarajan; Sharada, Duddu S. Journal: Bioorganic & medicinal chemistry letters Issue: Volume 27:Issue 7(2017) Page Start: 1593 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Design and characterisation of piperazine-benzofuran integrated dinitrobenzenesulfonamide as Mycobacterium tuberculosis H37Rv strain inhibitors. (1st January 2021) Authors: Murthy, Vallabhaneni S.; Tamboli, Yasinalli; Krishna, Vagolu Siva; Sriram, Dharmarajan; Akber Ansari, Siddique; Alarfaj, Abdullah A.; Hirad, Abdurahman H.; Vijayakumar, Vijayaparthasarathi Journal: Journal of enzyme inhibition and medicinal chemistry Issue: Volume 36:Number 1(2021) Page Start: 1751 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Design and synthesis of new indanol-1, 2, 3-triazole derivatives as potent antitubercular and antimicrobial agents. Issue 22 (15th November 2020) Authors: Phatak, Pramod S.; Bakale, Rajubai D.; Kulkarni, Ravibhushan S.; Dhumal, Sambhaji T.; Dixit, Prashant P.; Krishna, Vagolu Siva; Sriram, Dharmarajan; Khedkar, Vijay M.; Haval, Kishan P. Journal: Bioorganic & medicinal chemistry letters Issue: Volume 30:Issue 22(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Design and synthesis of purine connected piperazine derivatives as novel inhibitors of Mycobacterium tuberculosis. Issue 22 (15th November 2020) Authors: Konduri, Srihari; Prashanth, Jyothi; Krishna, Vagolu Siva; Sriram, Dharmarajan; Behera, J.N.; Siegel, Dionicio; Rao, Koya Prabhakara Journal: Bioorganic & medicinal chemistry letters Issue: Volume 30:Issue 22(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Novel 1, 3, 4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis. (20th March 2019) Authors: Makane, Vitthal B; Krishna, Vagolu Siva; Krishna, Eruva Vamshi; Shukla, Manjulika; Mahizhaveni, Balakrishnan; Misra, Sunil; Chopra, Sidharth; Sriram, Dharmarajan; Azger Dusthackeer, Vijayan N; Rode, Haridas B Journal: Future medicinal chemistry Issue: Volume 11:Number 6(2019) Page Start: 499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Novel fluoroquinolones containing 2‐arylamino‐2‐oxoethyl fragment: Design, synthesis, evaluation of antibacterial and antituberculosis activities and molecular modeling studies. (2nd January 2022) Authors: Kulabaş, Necla; Türe, Aslı; Bozdeveci, Arif; Krishna, Vagolu Siva; Alpay Karaoğlu, Şengül; Sriram, Dharmarajan; Küçükgüzel, İlkay Journal: Journal of heterocyclic chemistry Issue: Volume 59:Number 5(2022) Page Start: 909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗